{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:24:51Z","timestamp":1795062291670,"version":"4.10.2"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.ijpharm.2007.12.024","type":"journal-article","created":{"date-parts":[[2007,12,26]],"date-time":"2007-12-26T13:55:47Z","timestamp":1198677347000},"page":"12-18","source":"Crossref","is-referenced-by-count":74,"title":["Application and limitation of inhibitors in drug\u2013transporter interactions studies"],"prefix":"10.1016","volume":"356","author":[{"given":"Qing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Strab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Kardos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrissa","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael J.","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2007.12.024_bib1","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1023\/A:1023847521767","article-title":"Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats","volume":"20","author":"Arimori","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib2","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1208\/aapsj080101","article-title":"Current industrial practices of assessing permeability and P-glycoprotein interaction","volume":"8","author":"Balimane","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/bdd.501","article-title":"Apparent active transport of MDMA is not mediated by P-glycoprotein: a comparison with MDCK and Caco-2 monolayers","volume":"27","author":"Bertelsen","year":"2006","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0006-291X(92)91593-F","article-title":"The MDR1 Gene Product, P-Glycoprotein, mediates the transport of the cardiac glycoside, digoxin","volume":"189","author":"De Lannoy","year":"1992","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clpt.2004.02.008","article-title":"Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers","volume":"76","author":"Ding","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib6","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0006-2952(02)01355-2","article-title":"Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man","volume":"64","author":"Goh","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/dmd.30.4.457","article-title":"Delineating the contribution of B-to-A transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT)","volume":"30","author":"Guo","year":"2002","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1568026013395010","article-title":"Assessing the absorption of new pharmaceuticals","volume":"1","author":"Hidalgo","year":"2001","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib9","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1124\/dmd.106.009290","article-title":"Drug-drug interaction between pitavastatin and various drugs via OATP1B1","volume":"34","author":"Hirano","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jps.2600640317","article-title":"Intersubject variation in absorption of digoxin in normal volunteers","volume":"64","author":"Huffman","year":"1975","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1023\/A:1018972102702","article-title":"Drug absorption limited by P-glycoprotein-mediated B-to-A drug transport in human intestinal epithelial Caco-2 cell layers","volume":"10","author":"Hunter","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/mol.64.3.610","article-title":"Breast cancer resistance protein exports sulfated estrogens but not free estrogens","volume":"64","author":"Imai","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/A:1012121632357","article-title":"Jejunal permeability: a comparison between the ussing chamber technique and the single-pass perfusion in humans","volume":"14","author":"Lennernas","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/toxsci\/kfj141","article-title":"Molecular characterization and inhibition of amanitin influx into human hepatocytes","volume":"91","author":"Letschert","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib15","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1023\/A:1026450326712","article-title":"Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers","volume":"17","author":"Liang","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(02)02764-4","article-title":"Evidence for a non-MDR1 component in digoxin secretion by human intestinal Caco-2 epithelial layers","volume":"458","author":"Lowes","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib17","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1211\/jpp.57.12.0006","article-title":"Sulfasalazine transport in in-vitro, ex-vivo and in-vivo absorption models: contribution of efflux carriers and their modulation by co-administration of synthetic nature-identical fruit extracts","volume":"57","author":"Mols","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/dmd.106.011288","article-title":"Effect of oral ketoconazole on intestinal first-pass effect of midazolam and fexofenadine in cynomolgus monkeys","volume":"35","author":"Ogasawara","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00280-006-0357-8","article-title":"Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins","volume":"60","author":"Pawarode","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib20","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1023\/B:PHAM.0000036913.90332.b1","article-title":"Transport characteristics of fexofenadine in the Caco-2 cell model","volume":"21","author":"Petri","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib21","first-page":"47","article-title":"Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein","volume":"60","author":"Rabindran","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib22","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1124\/dmd.106.009530","article-title":"Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells","volume":"34","author":"Sai","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib23","first-page":"227","article-title":"The mechanism of ATP-dependent multidrug transport by P-glycoprotein","volume":"643","author":"Shapiro","year":"1998","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.bjp.0706974","article-title":"Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters","volume":"150","author":"Schrickx","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib25","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0022-3565(24)38782-8","article-title":"Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia","volume":"296","author":"Stephens","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.2042-7158.1990.tb05418.x","article-title":"Contribution of passive transport mechanisms to the intestinal absorption of beta-lactam antibiotics","volume":"42","author":"Sugawara","year":"1990","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0928-0987(03)00204-5","article-title":"Exploring the quantitative relationship between the level of MDR1 transcript, protein and function using digoxin as a marker of MDR1-dependent drug efflux activity","volume":"21","author":"Taipalensuu","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1023\/A:1016196514217","article-title":"Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE","volume":"19","author":"Tang","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib29","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1023\/A:1025001131513","article-title":"Novel experimental parameters to quantify the modulation of A-to-B and B-to-A transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium","volume":"20","author":"Troutman","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1248\/bpb.29.90","article-title":"Effects of progesterone and norethisterone on cephalexin transport and peptide transporter PEPT1 expression in human intestinal cell line Caco-2","volume":"29","author":"Watanabe","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1124\/dmd.104.003442","article-title":"Expression, localization, and functional characteristics of breast cancer resistance protein in Caco-2 cells","volume":"33","author":"Xia","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib32","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1124\/dmd.106.011866","article-title":"Interactions of Cyclosporin A with breast cancer resistance protein","volume":"35","author":"Xia","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2007.12.024_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/mp050113v","article-title":"Breast cancer resistance protein (Bcrp\/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse","volume":"3","author":"Zaher","year":"2006","journal-title":"Mol. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517307010708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517307010708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T20:26:33Z","timestamp":1737750393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517307010708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0378517307010708"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2007.12.024","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}